Jpmorgan Chase & CO Evogene Ltd. Put Options Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EVGN
# of Institutions
32Shares Held
4.08MCall Options Held
23KPut Options Held
0-
Silverarc Capital Management, LLC3.09MShares$2.01 Million0.78% of portfolio
-
Morgan Stanley New York, NY284KShares$184,6310.0% of portfolio
-
Eidelman Virant Capital117KShares$76,0500.07% of portfolio
-
Lpl Financial LLC Fort Mill, SC66.8KShares$43,4420.0% of portfolio
-
Ubs Group Ag62.5KShares$40,6210.0% of portfolio
About Evogene Ltd.
- Ticker EVGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,202,000
- Market Cap $26.8M
- Description
- Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...